Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Storm Newton

Daily pill on NHS offers new hope for hundreds with lung cancer

Photo issued by NHS England of a member of staff looking at the results of a lung scan - (PA)

A groundbreaking daily pill has been approved for routine use by the NHS, offering new hope for hundreds of lung cancer patients.

The drug Osimertinib (Tagrisso), developed by AstraZeneca, has been shown to double survival time in specific cases and will now be routinely available following a recommendation from the National Institute for Health and Care Excellence (Nice).

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.